Aldeyra The (ALDX) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of Aldeyra The and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aldeyra The logo
ALDX
Aldeyra The
$54M
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$59M
$11.75HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

Total return — ALDX vs INKT

growth of $100 · dividends reinvested · last 5y
ALDX -89.3% (-36.0%/yr)INKT -89.8% (-36.7%/yr)ALDX compounded faster over this window
050100150Start $10020222023202420252026$11$10
ALDX INKT

ALDX vs INKT: by the numbers

  • •INKT is the larger company ($59M vs $54M market cap).

Metrics side by side

Valuation

MetricALDXINKT
P/B ratio1.44N/A

Profitability

MetricALDXINKT
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-60.85%N/A
ROIC-63.52%-604.20%

Growth (annualized)

MetricALDXINKT
Total return CAGR (5Y)-36.54%N/A

Go deeper

Full ALDX analysisFull INKT analysisInteractive comparison tool

Dig into the metrics

Aldeyra The ROEMiNK Therapeutics ROEAldeyra The operating marginMiNK Therapeutics operating marginAldeyra The revenue growthMiNK Therapeutics revenue growthAldeyra The free cash flowMiNK Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.